Biotech

All Articles

Basilea ratings $268M BARDA backing for antifungals, anti-biotics

.Basilea Pharmaceutica's work establishing brand new antifungals has actually gotten a considerable ...

Capricor markets Europe civil liberties to late-stage DMD therapy for $35M

.Having actually gathered up the U.S. civil liberties to Capricor Rehabs' late-stage Duchenne muscle...

FDA junks adcomm for Applied's uncommon ailment drug

.After pushing the decision meeting for Applied Therapies' metabolic condition medication govorestat...

Novo inks $600M NanoVation package to analyze genetic medicines ex-liver

.Novo Nordisk is actually proceeding its own press right into genetic medications, accepting pay Nan...

Innovent links cytokine to colon cancer feedbacks

.Innovent Biologics has actually made the case that its own gate inhibitor-cytokine fusion healthy p...

Merck, Daiichi ADC reaches goal in stage 3 lung cancer cells study

.A stage 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (A...

Rakovina strengthens artificial intelligence concentrate with collab to pick cancer aim ats

.5 months after Rakovina Therapies pivoted towards artificial intelligence, the cancer-focused biote...

Ascendis' dwarfism medication hits in phase 3, threatens BioMarin

.Ascendis Pharma has actually emerged as a possible risk to BioMarin's Voxzogo, stating stage 3 grow...

Despite ph. 3 miss, Alkeus observes path ahead of time for eye illness asset

.Though Alkeus Pharmaceuticals' dental eye disease resource stopped working to dramatically lessen g...

Kairos goes social along with $6M IPO to fund trials of cancer cells medicine

.Along with a trio of biotechs attacking the Nasdaq on Friday, it was actually quick and easy to mis...